Virus-like particles induce robust human T-helper cell responses.

Virus-like particles induce robust human T-helper cell responses.

Among synthetic vaccines, virus-like particles (VLPs) are used for their ability to induce strong humoral responses. Very little is reported on VLP-based-vaccine-induced CD4(+) T-cell responses, despite the requirement of helper T cells for antibody isotype switching. Further knowledge on helper T...

書誌詳細
主要な著者:	Braun, M, Jandus, C, Maurer, P, Hammann-Haenni, A, Schwarz, K, Bachmann, M, Speiser, D, Romero, P
フォーマット:	Journal article
言語:	English
出版事項:	2012

類似資料

Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles.
著者:: Schwarz, K, 等
出版事項: (2005)

Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses
著者:: Alam, Mohammad Murshid, 等
出版事項: (2022)

Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients.
著者:: Goldinger, S, 等
出版事項: (2012)

Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles.
著者:: Spohn, G, 等
出版事項: (2005)

Virus-like particles as a modular system for novel vaccines.
著者:: Lechner, F, 等
出版事項: (2002)

The coming of age of virus-like particle vaccines.
著者:: Jennings, G, 等
出版事項: (2008)

Special Issue “Virus-Like Particle Vaccines”
著者:: Monique Vogel, 等
出版事項: (2020-08-01)

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies.
著者:: Jegerlehner, A, 等
出版事項: (2010)

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
著者:: Bessa, J, 等
出版事項: (2008)

The kinetics of a memory B cell response to virus like particles in mice
著者:: Zabel, F, 等
出版事項: (2012)

The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference
著者:: Paul Engeroff, 等
出版事項: (2019-01-01)

Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies.
著者:: Ruedl, C, 等
出版事項: (2005)

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
著者:: Anne-Cathrine S. Vogt, 等
出版事項: (2022-06-01)

Use of virus-like particles for therapeutic vaccination against addiction and other chronic diseases
著者:: Bachmann, M
出版事項: (2005)

Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection.
著者:: Kopf, M, 等
出版事項: (2000)

Long-term human T-helper lines producing specific helper factor reactive to influenza virus.
著者:: Fischer, A, 等
出版事項: (1981)

Versatile virus-like particle carrier for epitope based vaccines
著者:: Tissot, A, 等
出版事項: (2010)

Bacterially produced recombinant influenza vaccines based on virus-like particles
著者:: Jegerlehner, A, 等
出版事項: (2013)

Generation of a virus‐like particles based vaccine against IgE
著者:: Gharailoo, Z, 等
出版事項: (2024)

T-helper cell-mediated proliferation and cytokine responses against recombinant Merkel cell polyomavirus-like particles.
著者:: Arun Kumar, 等
出版事項: (2011-01-01)

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
著者:: Klimek, L, 等
出版事項: (2014)

Heterogeneous antibody repertoire of marginal zone B cells specific for virus-like particles.
著者:: Gatto, D, 等
出版事項: (2007)

Interaction of viral capsid-derived virus-like particles (VLPs) with the innate immune system
著者:: Mohsen, M, 等
出版事項: (2018)

Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
著者:: Spohn, G, 等
出版事項: (2008)

Adjusted particle size eliminates the need of linkage of antigen and adjuvants for appropriated T cell responses in virus-like particle-based vaccines.
著者:: Gomes, A, 等
出版事項: (2017)

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
著者:: Ambühl, P, 等
出版事項: (2007)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
著者:: Klimek, L, 等
出版事項: (2018)

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.
著者:: Lorena Itatí Ibañez, 等
出版事項: (2013-01-01)

Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells.
著者:: Engeroff, P, 等
出版事項: (2017)

T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
著者:: Bachmann, M, 等
出版事項: (1995)

Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines
著者:: Dominik A. Rothen, 等
出版事項: (2024-09-01)

Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity
著者:: Sucheta D’Sa, 等
出版事項: (2022-04-01)

COMPLEMENTATION OF H-2-LINKED IR GENES - USE OF HELPER FACTOR TO ANALYZE RESPONSES TO GLYPHE
著者:: Baltz, M, 等
出版事項: (1978)

Preclinical antihypertensive efficacy and immunogenicity in humans of a vaccine against angiotensin II based on virus-like particles (VLPs)
著者:: Tissot, A, 等
出版事項: (2005)

Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus.
著者:: Kündig, T, 等
出版事項: (1993)

Conditions for inducing T helper cells in vitro.
著者:: Kontiainen, S, 等
出版事項: (1975)

Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
著者:: Brune, K, 等
出版事項: (2016)

Yellow fever virus vaccination: an emblematic model to elucidate robust human immune responses
著者:: Amandine Bovay, 等
出版事項: (2021-08-01)

Bacterially produced recombinant influenza vaccines based on virus-like particles.
著者:: Andrea Jegerlehner, 等
出版事項: (2013-01-01)

Vernal keratoconjunctivitis in human immunodeficiency virus – The possible role of T-helper 1–T-helper 2 shift
著者:: Shweta Agarwal, 等
出版事項: (2018-01-01)